Contract

ADHD Annual Review /prescribing and monitoring

  • NHS SUFFOLK AND NORTH EAST ESSEX INTEGRATED CARE BOARD

F03: Contract award notice

Notice identifier: 2025/S 000-029652

Procurement identifier (OCID): ocds-h6vhtk-052be5

Published 3 June 2025, 5:44pm



Section one: Contracting authority

one.1) Name and addresses

NHS SUFFOLK AND NORTH EAST ESSEX INTEGRATED CARE BOARD

Endeavour House, Russell Road

Ipswich

IP12BX

Contact

Jane Garnett

Email

procurement@snee.nhs.uk

Country

United Kingdom

Region code

UKH14 - Suffolk

NHS Organisation Data Service

QJG

Internet address(es)

Main address

https://suffolkandnortheastessex.icb.nhs.uk/

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

ADHD Annual Review /prescribing and monitoring

two.1.2) Main CPV code

  • 85100000 - Health services

two.1.3) Type of contract

Services

two.1.4) Short description

The ICB is commissioning a service to support the GP Practices transferring lists of patients to an Independent Sector Provider (ISP) who will adhere to the NICE NG87 guidance https://www.nice.org.uk/guidance/ng87 and provide the overdue annual review, recommend adjustment to medication where required as the specialist provider and where necessary the primary care element of ADHD patient's Shared Care Arrangement using Electronic Prescribing Service (EPS). This is only applicable to specific cohorts of adult patients across Suffolk and North East Essex ICB (SNEE ICB) area and registered with a SNEE ICB GP practice.

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £711,580

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKH14 - Suffolk
  • UKH34 - Essex Haven Gateway
Main site or place of performance

Suffolk and North East Essex locality

two.2.4) Description of the procurement

Suffolk and North East Essex (SNEE) ICB is urgently awarding a service to support ADHD annual reviews for adult patients who in some cases require a prescribing and monitoring service for ADHD medications. This service will take on specialist provider and/or the primary care responsibilities as defined by the shared care agreements for these medications. This service is being set up in response to receiving formal notice from the Suffolk Local Medical Council (LMC) and North & South Essex LMC that they have advised GP practices in SNEE to decline from participating in shared care agreements for ADHD medications for this cohorts of patients. This includes withdrawing from existing shared care agreements. To enable this to take place safely, a specialist provider oversight is required and will include any backlog of overdue annual reviews, or other monitoring review of patient medication.

The objectives of the service are to:

• Provide patients with appropriate and safe care within a specialist provider service setting.

• Allow continued patient access to ongoing medication services.

The service shall be available to all patients within SNEE who are registered with a GP practice within West Suffolk, Ipswich and East Suffolk, or North East Essex who have been identified as being without a specialist provider to oversee their ADHD prescribing and management. Access to the service is by transfer of patient information from GPs, ESNEFT, NSFT or EPUT.

The provider will accept patients who have previously been diagnosed with ADHD, have completed a minimum of 12 weeks of titration and have been stabilised on treatment and may or may not require an immediate annual review.

NHS Suffolk and North East Essex Integrated Care Board are awarding the contract named within this notice due to an urgent circumstance which is outlined within the Health Care Services (Provider Selection Regime) Regulations 2023.

This contract will start on the 9th June 2025 for 12 months (1 year).

There will be an option to extend by a further 12 months (1 year) from 9th June 2026 - 8th June 2027.

Dates / extensions will depend on inclusion of ongoing meds for the 'stranded' cohorts identified.

The value of this contract is maximum estimation based upon all patient data available at the time, therefore there is the potential for variation once the entirety of the circumstances and the number of shared care arrangements are understood with greater detail.

The ICB may wish to introduce additional services during the lifetime of the contract ("Contract modifications"). Such contract modifications will be contemplated where additional requirements are similar and or complementary to the services already included in the Specification, at any given time. Such expansion would be by the addition of services commissioned by the Authority as named in the Contract Award Notice. To this end, after the award of contract, there is a possibility that the contract may be varied as allowable in accordance with the Health Care Services (Provider Selection Regime) Regulations 2023.

two.2.5) Award criteria

Quality criterion - Name: To address immediate risks to safety and quality of care. / Weighting: 100

Price - Weighting: 0

two.2.11) Information about options

Options: Yes

Description of options

There will be an option to extend by a further 12 months (1 year) from 9th June 2026 - 8th June 2027.


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The procurement falls outside the scope of application of the regulations

Explanation:

This contract has been awarded under the urgent circumstances provision of the Provider Selection Regime (PSR). This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This award is being made urgently and the reason for the urgency was not foreseen by the ICB for the reasons outlined within this notice. This award is being made in order to prevent risk to patient and public safety, and the ICB is not able to satisfy the requirements of regulations 6 - 13 for the reasons outlined below.

In order to mobilise the interim service within the timeframe given by the notice of GP practices in Suffolk and NE Essex and to prevent harm to the identified cohorts, it is imperative that the provider has the capability, capacity and clinical processes required within a short turnaround time.

Insert Award decision-makers: Executive Committee 7th April 2025.

No conflicts of interest, or potential conflicts of interest, were declared by any decision makes.

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No


Section five. Award of contract

Title

ADHD Annual Review /prescribing and monitoring

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

2 June 2025

five.2.2) Information about tenders

Number of tenders received: 1

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

The Centre for ADHD Research and Excellence

Unit 8 The Courtyard Gaulby Lane

Stoughton

LE2 2FL

Country

United Kingdom

NUTS code
  • UKF22 - Leicestershire CC and Rutland
NHS Organisation Data Service

L4Q5D

The contractor is an SME

Yes

five.2.4) Information on value of contract/lot (excluding VAT)

Total value of the contract/lot: £711,580


Section six. Complementary information

six.4) Procedures for review

six.4.1) Review body

NHS Suffolk and North East Essex Integrated Care Board

Endeavour House, Russell Road

Ipswich

IP1 2BX

Email

procurement@snee.nhs.uk

Country

United Kingdom